349 related articles for article (PubMed ID: 17089258)
1. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
Busse O; Diener HC; Grond M
Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258
[No Abstract] [Full Text] [Related]
2. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
3. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
4. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
Diener C
MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
[No Abstract] [Full Text] [Related]
5. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
Einecke D
MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
[No Abstract] [Full Text] [Related]
6. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
Lutsep HL
J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
[TBL] [Abstract][Full Text] [Related]
7. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy: a neurology perspective.
Brass LM
Manag Care; 2000 Oct; 9(10 Suppl):13-5. PubMed ID: 11729420
[No Abstract] [Full Text] [Related]
9. Antiplatelet therapy: a neurology perspective.
Brass LM
Manag Care; 2000 May; 9(5 Suppl):15-7. PubMed ID: 11729408
[No Abstract] [Full Text] [Related]
10. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
11. ProFESS trial: any lessons to learn for future anti-platelet trials?
Sharma JC; Vassallo M; Ross IN
Int J Stroke; 2009 Dec; 4(6):458-60. PubMed ID: 19930057
[No Abstract] [Full Text] [Related]
12. The approach to optimizing stroke care.
Panagos PD
Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
[TBL] [Abstract][Full Text] [Related]
13. [Clopidogrel protection is not increased further by ASS!].
Bogousslavsky J
Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
[No Abstract] [Full Text] [Related]
14. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
15. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Simmons BB; Yeo A; Fung K; ;
Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet drugs for ischemic stroke prevention.
Leys D; Balucani C; Cordonnier C
Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
[TBL] [Abstract][Full Text] [Related]
17. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
18. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelets and stroke outcomes: state of the science.
Meyer D
Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767
[TBL] [Abstract][Full Text] [Related]
20. [Primary and secondary prevention of stroke. Prevention is better than healing].
Stiefelhagen P
MMW Fortschr Med; 2004; 146 Suppl 1():12-7; quiz 18-9. PubMed ID: 15493414
[No Abstract] [Full Text] [Related]
[Next] [New Search]